Pricing Log in Create free account

Annexon, Inc. (ANNX) vs OmniAb, Inc. (OABI)

Annexon, Inc. and OmniAb, Inc. are both Biotechnology companies. Annexon, Inc. and OmniAb, Inc. are of similar size ($759.3M and $704.5M). Annexon, Inc. has the higher net margin (0.00% vs −108.1%) and the higher return on invested capital (0.00% vs −15.8%). Across the 13 metrics below, OmniAb, Inc. leads on 8 and Annexon, Inc. on 5.

Valuation

Metric ANNX OABI Biotechnology median
P/E n/m n/m 10.60
P/S n/m 16.14 9.40
P/B 4.55 2.61 2.13
Price to free cash flow n/m 272.71 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 14.54 9.02
Earnings yield (27.55%) (6.77%) (32.88%)
Free cash flow yield (22.83%) 0.37% (23.13%)

Profitability

Metric ANNX OABI Biotechnology median
Gross margin 0.00% 97.65% 68.51%
Operating margin 0.00% (115.89%) 0.00%
Net margin 0.00% (108.11%) 0.00%
Free cash flow margin 0.00% 5.92% 0.00%
Return on equity (105.26%) (16.51%) (51.96%)
Return on assets (79.38%) (14.48%) (46.06%)
Return on invested capital 0.00% (15.75%) 0.00%

Growth

Metric ANNX OABI Biotechnology median
Revenue growth (TTM) — 90.63% 6.76%
EPS growth (last fiscal year) (32.67%) 6.56% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ANNX OABI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.53 4.21 4.97
Net debt to EBITDA 1.11 1.12 1.01

Dividend

Metric ANNX OABI Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ANNX OABI Biotechnology median
Market cap 759.27m 704.51m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack